Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Wintrust Financial Corp (WTFC)

Wintrust Financial Corp (WTFC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Wintrust Financial Corporation Announces Cash Dividends

WTFC : 114.39 (-1.29%)
Wintrust: Q3 Earnings Snapshot

Wintrust: Q3 Earnings Snapshot

WTFC : 114.39 (-1.29%)
Wintrust Financial Corporation Reports Third Quarter and Year-to-Date Results

WTFC : 114.39 (-1.29%)
Why Earnings Season Could Be Great for Wintrust Financial (WTFC)

Investors are always looking for stocks that are poised to beat at earnings season and Wintrust Financial WTFC may be one such company. The firm has earnings coming up pretty soon, and events are shaping...

WTFC : 114.39 (-1.29%)
Wintrust: Q2 Earnings Snapshot

Wintrust: Q2 Earnings Snapshot

WTFC : 114.39 (-1.29%)
Wintrust: Q1 Earnings Snapshot

Wintrust: Q1 Earnings Snapshot

WTFC : 114.39 (-1.29%)
Wintrust: Q4 Earnings Snapshot

Wintrust: Q4 Earnings Snapshot

WTFC : 114.39 (-1.29%)
Wintrust: Q3 Earnings Snapshot

Wintrust: Q3 Earnings Snapshot

WTFC : 114.39 (-1.29%)
Wintrust: Q2 Earnings Snapshot

Wintrust: Q2 Earnings Snapshot

WTFC : 114.39 (-1.29%)
Wintrust: Q1 Earnings Snapshot

Wintrust: Q1 Earnings Snapshot

WTFC : 114.39 (-1.29%)

Barchart Exclusives

Thanks to Wall Street, Novo Nordisk Stock is Now a Buy
Novo Nordisk has lost about a quarter of its value since the end of June. Meanwhile, indications are that its diabetes and weight-loss drugs may be useful in fighting cardiovascular disease, arthritis, opioid and alcohol addiction, and Alzheimer's. Novo remains a leader in the sector, and is trading at a valuation a third cheaper than competitor, Eli Lilly. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar